Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
4,629,882
-
Share change
-
+4,629,882
-
Total reported value
-
$69,305,000
-
Price per share
-
$14.97
-
Number of holders
-
33
-
Value change
-
+$69,305,017
-
Number of buys
-
33
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q3 2014
As of 30 Sep 2014,
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,629,882 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT CO LLP, Capital Research Global Investors, RS INVESTMENT MANAGEMENT CO LLC, Pentwater Capital Management LP, FEDERATED INVESTORS INC /PA/, SABBY MANAGEMENT, LLC, BlackRock Fund Advisors, DEUTSCHE BANK AG\, BlackRock Institutional Trust Company, N.A., and MORGAN STANLEY.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.